AngioDynamics Soars 10.46% Ahead of Earnings

AngioDynamics' stock price surged by 10.46% in pre-market trading on April 2, 2025, marking a significant rise ahead of its quarterly earnings release.

AngioDynamics is set to announce its quarterly earnings on April 2, 2025. Analysts anticipate an earnings per share (EPS) of -$0.11. Investors are hopeful that the company will not only meet but exceed this estimate and provide positive guidance for the next quarter. Historically, AngioDynamics has shown mixed results, with the previous earnings release beating EPS by $0.07 but resulting in a 0.0% drop in share price the following trading session.

AngioDynamics' stock has performed well over the past 52 weeks, with shares up 51.97%. This positive performance has likely contributed to the bullish sentiment among long-term shareholders ahead of the earnings release. The company's financial health is also a point of interest, with a net margin of -14.74% and a return on equity (ROE) of -5.6%, both of which are impressive compared to industry averages. Additionally, AngioDynamics has a debt-to-equity ratio of 0.03, indicating a healthier balance between debt and equity.